Hepatitis Monthly

Published by: Kowsar

IFN-γ siRNA Effectively Knocked Down IFN-γ Gene Expression and Reduced Cytokine Secretion in Peripheral Blood Mononuclear Cells of Patients with Autoimmune Hepatitis

Farinaz Behfarjam 1 , Mohammad Hossein Sanati 1 , * , Zohreh Jadali 2 , Zahra Soheila Soheili 1 , Siavash Nasseri Moghaddam 3 , Mitra Ataei 1 and Sepideh Nikfam 3
Authors Information
1 Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
2 School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
3 Digestive Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Hepatitis Monthly: August 2018, 18 (8); e63676
  • Published Online: July 25, 2018
  • Article Type: Research Article
  • Received: November 5, 2017
  • Revised: April 4, 2018
  • Accepted: April 12, 2018
  • DOI: 10.5812/hepatmon.63676

To Cite: Behfarjam F, Sanati M H, Jadali Z, Soheili Z S, Nasseri Moghaddam S, et al. IFN-γ siRNA Effectively Knocked Down IFN-γ Gene Expression and Reduced Cytokine Secretion in Peripheral Blood Mononuclear Cells of Patients with Autoimmune Hepatitis, Hepat Mon. 2018 ; 18(8):e63676. doi: 10.5812/hepatmon.63676.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Footnote
References
  • 1. Liberal R, Longhi MS, Mieli-Vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2011;25(6):653-64. doi: 10.1016/j.bpg.2011.09.009. [PubMed: 22117632].
  • 2. Ortiz JEP, Preciado J, Pacheco SH. Autoimmune hepatitis. Rev Col Gastroenterol. 2012;27(4):301-12.
  • 3. Liberal R, Grant CR, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: a comprehensive review. J Autoimmun. 2013;41:126-39. doi: 10.1016/j.jaut.2012.11.002. [PubMed: 23218932].
  • 4. Ferri Liu PM, de Miranda DM, Fagundes ED, Ferreira AR, Simoes e Silva AC. Autoimmune hepatitis in childhood: the role of genetic and immune factors. World J Gastroenterol. 2013;19(28):4455-63. doi: 10.3748/wjg.v19.i28.4455. [PubMed: 23901220]. [PubMed Central: PMC3725369].
  • 5. Behfarjam F, Sanati MH, Nasseri Moghaddam S, Ataei M, Nikfam S, Jadali Z. Role of Th1/Th2 cells and related cytokines in autoimmune hepatitis. Turk J Gastroenterol. 2017;28(2):110-4. doi: 10.5152/tjg.2017.17501. [PubMed: 28119269].
  • 6. Skurkovich SV, Skurkovich B, Kelly JA. Anticytokine therapy – new approach to the treatment of autoimmune and cytokine-disturbance diseases. Med Hypotheses. 2002;59(6):770-80. doi: 10.1016/s0306-9877(02)00346-8.
  • 7. Skurkovich S, Skurkovich B, Kelly J. Anticytokine therapy, particularly anti-IFN-gamma, in Th1-mediated autoimmune diseases. Expert Rev Clin Immunol. 2005;1(1):11-25. doi: 10.1586/1744666X.1.1.11. [PubMed: 20477651].
  • 8. Li L, Munoz-Culla M, Carmona U, Lopez MP, Yang F, Trigueros C, et al. Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells. Biomaterials. 2016;98:143-51. doi: 10.1016/j.biomaterials.2016.05.006. [PubMed: 27187278].
  • 9. Koenig O, Walker T, Perle N, Zech A, Neumann B, Schlensak C, et al. New aspects of gene-silencing for the treatment of cardiovascular diseases. Pharmaceuticals (Basel). 2013;6(7):881-914. doi: 10.3390/ph6070881. [PubMed: 24276320]. [PubMed Central: PMC3816708].
  • 10. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929-38. doi: 10.1016/s0168-8278(99)80297-9.
  • 11. Liu K, Liu PC, Liu R, Wu X. Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. Med Sci Monit Basic Res. 2015;21:15-20. doi: 10.12659/MSMBR.893327. [PubMed: 25664686]. [PubMed Central: PMC4332266].
  • 12. Zheng X, Suzuki M, Ichim TE, Zhang X, Sun H, Zhu F, et al. Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells. J Immunol. 2010;184(11):6457-64. doi: 10.4049/jimmunol.0901717. [PubMed: 20435931].
  • 13. Oo YH, Hubscher SG, Adams DH. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int. 2010;4(2):475-93. doi: 10.1007/s12072-010-9183-5. [PubMed: 20827405]. [PubMed Central: PMC2900560].
  • 14. Lapierre P, Beland K, Alvarez F. Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis. Transl Res. 2007;149(3):107-13. doi: 10.1016/j.trsl.2006.11.010. [PubMed: 17320796].
  • 15. Seyhan AA. RNAi: a potential new class of therapeutic for human genetic disease. Hum Genet. 2011;130(5):583-605. doi: 10.1007/s00439-011-0995-8. [PubMed: 21537948].
  • 16. Burnett JC, Rossi JJ, Tiemann K. Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol J. 2011;6(9):1130-46. doi: 10.1002/biot.201100054. [PubMed: 21744502]. [PubMed Central: PMC3388104].
  • 17. Pollard KM, Cauvi DM, Toomey CB, Morris KV, Kono DH. Interferon-gamma and systemic autoimmunity. Discov Med. 2013;16(87):123-31. [PubMed: 23998448]. [PubMed Central: PMC3934799].
  • 18. Hu X, Ivashkiv LB. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity. 2009;31(4):539-50. doi: 10.1016/j.immuni.2009.09.002. [PubMed: 19833085]. [PubMed Central: PMC2774226].
  • 19. Reinisch W, de Villiers W, Bene L, Simon L, Racz I, Katz S, et al. Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study. Inflamm Bowel Dis. 2010;16(2):233-42. doi: 10.1002/ibd.21038. [PubMed: 19637334].
  • 20. Niimi N, Kohyama K, Matsumoto Y. Therapeutic gene silencing with siRNA for IL-23 but not for IL-17 suppresses the development of experimental autoimmune encephalomyelitis in rats. J Neuroimmunol. 2013;254(1-2):39-45. doi: 10.1016/j.jneuroim.2012.08.015. [PubMed: 22989513].
  • 21. Li R, Zheng X, Popov I, Zhang X, Wang H, Suzuki M, et al. Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis. J Transl Med. 2012;10:19. doi: 10.1186/1479-5876-10-19. [PubMed: 22289162]. [PubMed Central: PMC3293054].
  • 22. Leung RK, Whittaker PA. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther. 2005;107(2):222-39. doi: 10.1016/j.pharmthera.2005.03.004. [PubMed: 15908010].
  • 23. Dykxhoorn DM, Lieberman J. Knocking down disease with siRNAs. Cell. 2006;126(2):231-5. doi: 10.1016/j.cell.2006.07.007. [PubMed: 16873051].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments